Shanghai Kai Kai Industry Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shanghai Kai Kai Industry Co Ltd with three other
companies in this sector in China:
Hybio Pharmaceutical Co Ltd
sales of 855.05 million Chinese Renmimbi [US$126.75 million]
of which 100%
was Medical and Pharmaceutical Manufacturing),
Henan Taloph Pharmaceutical Stock Company Limited
(953.31 million Chinese Renmimbi [US$141.32 million]
of which 68%
was Medicine Manufacturing), and
Zhejiang Yatai Pharmaceutical Co.,Limited
(862.87 million Chinese Renmimbi [US$127.91 million]
of which 53%
was CRO Service).
During the year ended December of 2016, sales at
Shanghai Kai Kai Industry Co Ltd were 905.28 million Chinese Renmimbi (US$134.20 million).
increase of 2.9%
versus 2015, when the company's sales were 879.44 million Chinese Renmimbi.
Sales of Commerce saw an increase
4.2% in 2016, from
797.99 million Chinese Renmimbi to 831.11 million Chinese Renmimbi.
Not all segments of Shanghai Kai Kai Industry Co Ltd experienced an increase in sales in 2016:
sales of Industry fell 15.6% to 36.21 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).
Shanghai Kai Kai Industry Co Ltd also experienced decreases in sales in
Other Operations (down 5.0% to 33.88 million Chinese Renmimbi)